Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Should you Book Profit on this Health Care Technology Stock - CRW?

Jun 22, 2022 | Team Kalkine
Should you Book Profit on this Health Care Technology Stock - CRW?

 

Craneware PLC (LON: CRW)

Craneware PLC (LON: CRW) is an FTSE AIM 100 Index listed company, focused on the licensing and development of computer software for the healthcare industry.

Investment Rationale – SELL at GBX 1,740.00

  • Profit Booking: CRW’s stock price has soared around 30% in the past month; and thus, investors can book profit as per their respective risk/return profile.
  • Profit Decline: During H1 FY22, there was a 34% YoY decrease in adjusted basic EPS due to amortization of acquired intangible assets.
  • Economic Slowdown: British economy contracted in April 2022, facing pressure from the rising fuel prices and household energy bills. It is reflecting the intensified cost-of-living crunch. Moreover, the interest rate worries, the US dollar hitting two-decade peaks, and subdued economic forecasts can continue to impact corporate profits and put pressure on equity markets.
  • Technical Indicator: The momentum oscillator 14-day RSI (~66.62) is close to the overbought zone, while the price has breached the upper Bollinger Band. Thus, the price can face retracement from the current levels.  

One Year Share Price Chart

 (Source: Refinitiv, Analysis conducted by Kalkine Group)

Valuation Methodology: Price/Earnings Approach (FY23E) (Illustrative)

Conclusion

Based on the decent notional gains, macroeconomic instabilities, bearish technical indicators, coupled with the unfavorable valuation conducted above, we have given a "SELL" recommendation on Craneware PLC at the current market price of GBX 1,740.00 (as of 22 June 2022, at 2:18 PM GMT+1). 

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: Investment decision should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and subject to the factors discussed above.

Note 3: Dividend Yield may vary as per the stock price movement.


Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…